The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda‐Gonçalves, Cármen Jerónimo, João Lobo et al.|Journal of Experimental & Clinical Cancer Research|2021Cited by 59
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell TumorsJoão Lobo, Cármen Jerónimo, Catarina Guimarães‐Teixeira et al.|Cancers|2020Cited by 38
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break RepairMohamed E. Elsesy, Wael Mansour, Su Jung Oh‐Hohenhorst et al.|Cancers|2020Cited by 21
Young oncologists’ perspective on the role and future of the clinician-scientist in oncologyKok Haw Jonathan Lim, Teresa Amaral, Alexios Matikas et al.|ESMO Open|2023Cited by 15
Career and Professional Development for Young OncologistsMaximilian J. Mair, Teresa Amaral, Claudia Cardone et al.|Oncology Research and Treatment|2022Cited by 5